In some pathological conditions such as in renal ischemia-reperfusion, glomerulonephritis and obstructive nephropathy, once released by kallikrein, BK contributes to kidney injury mainly by activation of its two receptors, B1R and B2R [61–63]. Here, BDKRB1 is linked to glomerulonephritis.